Description
Cazanat™ is a quality assured generic of Cabozantinib used to treat advanced renal cell carcinoma (RCC), and hepatocellular carcinoma (HCC) in patients who were previously treated with sorafenib. It’s also used to treat differentiated thyroid cancer (DTC) that has progressed after VEGFR-targeted treatment in patients who can no longer be treated with radioactive iodine. It’s produced in a US FDA approved factory in India.
Bottle Size : 30 Tablets
Active Ingredients : Cabozantinib
Produced by Natco Pharma Ltd®